- $153.16bn
- $245.94bn
- $121.57bn
- 94
- 78
- 77
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108,942 | 103,564 | 116,385 | 121,427 | 121,572 |
Cost of Revenue | |||||
Gross Profit | 74,502 | 70,443 | 77,935 | 83,214 | 84,810 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 87,817 | 86,071 | 95,568 | 107,386 | 98,258 |
Operating Profit | 21,125 | 17,493 | 20,817 | 14,041 | 23,314 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16,996 | 14,065 | 19,093 | 9,284 | 20,478 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13,323 | 10,701 | 13,834 | 4,925 | 15,107 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13,057 | 10,534 | 14,159 | 5,370 | 15,389 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13,057 | 10,534 | 14,159 | 5,370 | 15,388 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.92 | 2.32 | 3 | 3.22 | 3.7 |
Dividends per Share |